Orthopedic and Surgical Specialty Company, LLC
Orthopedic and Surgical Specialty Company, LLC was paid $1.12M by Medicaid between Jan 2018 and Nov 2024, across 31 billing codes. Its largest line is C1713, Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) — 85% of everything it billed.
PHOENIX, AZ 85008
Next to other General Acute Care Hospital providers in Arizona
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,787 | $226K | |
| 2019 | 2,457 | $245K | |
| 2020 | 1,682 | $203K | |
| 2021 | 2,671 | $194K | |
| 2022 | 13 | $0.00 | |
| 2023 | 80 | $76K | |
| 2024incomplete | 2,610 | $179K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 85% | 824 | 751 | $955K |
| C1776 | Joint device (implantable) | 15% | 42 | 41 | $169K |
| 81025 | <1% | 277 | 254 | $24.73 | |
| G0378 | Hospital observation service, per hour | <1% | 57 | 37 | $18.01 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 1,450 | 1,283 | $0.00 |
| 85610 | 0% | 82 | 71 | $0.00 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 421 | 388 | $0.00 |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 0% | 614 | 100 | $0.00 |
| 97116 | 0% | 18 | 13 | $0.00 | |
| 97161 | 0% | 24 | 24 | $0.00 | |
| 82947 | 0% | 14 | 13 | $0.00 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 415 | 370 | $0.00 |
19 more codes
| 36415 | Collection of venous blood by venipuncture | 0% | 625 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 1,851 | $0.00 |
| 80048 | Basic metabolic panel (calcium, ionized) | 0% | 142 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 522 | $0.00 |
| 80053 | Comprehensive metabolic panel | 0% | 18 | $0.00 |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 0% | 154 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 914 | $0.00 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 0% | 402 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 1,566 | $0.00 |
| J3490 | Unclassified drugs | 0% | 638 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 106 | $0.00 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 0% | 41 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 165 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 542 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 36 | $0.00 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 0% | 84 | $0.00 |
| 85027 | 0% | 105 | $0.00 | |
| 85730 | 0% | 78 | $0.00 | |
| 94760 | 0% | 73 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.